1h Free Analyst Time
The Predictive Genetics Market grew from USD 1.25 billion in 2023 to USD 1.47 billion in 2024. It is expected to continue growing at a CAGR of 18.31%, reaching USD 4.05 billion by 2030. Speak directly to the analyst to clarify any post sales queries you may have.
Predictive genetics, a rapidly evolving sector within personalized medicine, aims to forecast an individual's susceptibility to diseases based on their genetic profile. This field's scope includes genetic testing to identify predispositions to conditions like cancer, cardiovascular diseases, and metabolic disorders, offering personalized preventive and therapeutic strategies. The growing necessity of predictive genetics is driven by increasing awareness of genetic conditions, technological advancements in genomics, and the burgeoning demand for personalized healthcare solutions. Applications span from clinical diagnostics and newborn screening to direct-to-consumer genetic testing, encompassing healthcare providers, research institutions, and biotechnological firms as major end-users.
Key growth influencers include advancements in next-generation sequencing (NGS), increased availability of genetic databases, and supportive government regulations promoting research in genomics. In addition, collaborations between pharmaceutical companies and diagnostics firms to create targeted therapies provide significant opportunities. Investors and firms are recommended to focus on partnerships that expand testing portfolios and integration of AI for efficient data interpretation, exploring untapped markets in developing regions which present lucrative growth avenues due to their rising healthcare infrastructure and spending.
However, the market faces limitations such as high costs of genetic testing, concerns over data privacy, and the potential for misinterpretation of genetic information, which can lead to ethical and psychological issues. Additionally, regulatory complexities and reimbursement challenges remain significant hurdles.
Innovation can thrive in areas such as developing cost-effective testing kits, enhancing accuracy through bioinformatics, and exploring non-invasive testing methods. Business growth can benefit from expanding the reach of educational initiatives to increase consumer understanding of potential genetic outcomes. The market's nature is highly competitive and dynamic, driven by continuous technological enhancements and evolving consumer expectations. However, companies that foster transparent communication about genetic data's role in healthcare and invest in securing patient data privacy stand to gain substantial advantages in this transformative market.
Understanding Market Dynamics in the Predictive Genetics Market
The Predictive Genetics Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.- Market Drivers
- Rising use of emerging technologies to gain valuable insights
- Adoption of new and growing class of medical diagnostic tests
- Increasing importance of targeted screening, surveillance, and prevention
- Market Restraints
- Lack of skilled workforce
- Market Opportunities
- Need of genetic predisposition DNA testing for type 2 diabetes and
- Rising investment and R&D in gene manipulation
- Market Challenges
- Companies’ concern over data security and privacy issues
Exploring Porter’s Five Forces for the Predictive Genetics Market
Porter’s Five Forces framework further strengthens the insights of the Predictive Genetics Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.Applying PESTLE Analysis to the Predictive Genetics Market
External macro-environmental factors deeply influence the performance of the Predictive Genetics Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.Analyzing Market Share in the Predictive Genetics Market
The Predictive Genetics Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.Evaluating Vendor Success with the FPNV Positioning Matrix in the Predictive Genetics Market
The Predictive Genetics Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.Strategic Recommendations for Success in the Predictive Genetics Market
The Predictive Genetics Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.Key Company Profiles
The report delves into recent significant developments in the Predictive Genetics Market, highlighting leading vendors and their innovative profiles. These include 23andMe, Inc., Color Health, Inc., CRISPR Therapeutics AG, deCODE genetics, Deep Genomics Incorporated, DNA N U Ltd., Editas Medicine, Inc., Gene by Gene, Ltd., Laboratory Corporation of America Holdings, Mapmygenome, myDNA Life Australia Pty Ltd., Myriad Genetics, Inc., Oxford Nanopore Technologies PLC, Positive Bioscience, Quest Diagnostics Incorporated, and Veritas Intercontinental SL.Market Segmentation & Coverage
This research report categorizes the Predictive Genetics Market to forecast the revenues and analyze trends in each of the following sub-markets:- Type
- Predispositional Testing
- Presymptomatic Testing
- Demographics
- 35 - 64
- 65+
- < 35
- Test Type
- Population Screening
- Susceptibility
- Setting Type
- Clinic
- Direct to Consumer
- Hospital
- Application
- Cancer
- Cardiovascular Disease
- Genetic Disease
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report provides a detailed overview of the market, exploring several key areas:
- Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
- Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
- Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
- Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
- Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.
Additionally, the report addresses key questions to assist stakeholders in making informed decisions:
- What is the current size of the market, and how is it expected to grow?
- Which products, segments, and regions present the most attractive investment opportunities?
- What are the prevailing technology trends and regulatory factors influencing the market?
- How do top vendors rank regarding market share and competitive positioning?
- What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?
Table of Contents
1. Preface
2. Research Methodology
4. Market Overview
5. Market Insights
6. Predictive Genetics Market, by Type
7. Predictive Genetics Market, by Demographics
8. Predictive Genetics Market, by Test Type
9. Predictive Genetics Market, by Setting Type
10. Predictive Genetics Market, by Application
11. Americas Predictive Genetics Market
12. Asia-Pacific Predictive Genetics Market
13. Europe, Middle East & Africa Predictive Genetics Market
14. Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
The leading players in the Predictive Genetics Market, which are profiled in this report, include:- 23andMe, Inc.
- Color Health, Inc.
- CRISPR Therapeutics AG
- deCODE genetics
- Deep Genomics Incorporated
- DNA N U Ltd.
- Editas Medicine, Inc.
- Gene by Gene, Ltd.
- Laboratory Corporation of America Holdings
- Mapmygenome
- myDNA Life Australia Pty Ltd.
- Myriad Genetics, Inc.
- Oxford Nanopore Technologies PLC
- Positive Bioscience
- Quest Diagnostics Incorporated
- Veritas Intercontinental SL
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 195 |
| Published | October 2024 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 1.47 Billion |
| Forecasted Market Value ( USD | $ 4.05 Billion |
| Compound Annual Growth Rate | 18.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 17 |
